TickerFactsScreenerDevelopers

TherapeuticsMD, Inc. (TXMD) — Operating Income

Annual figures by fiscal year, from SEC filings.

2011: -$5.43M2012: -$16.15M2013: -$25.81M2014: -$54.04M2015: -$85.19M2016: -$90.25M2017: -$77.63M2018: -$130.22M2019: -$151.21M2020: -$155.54M2021: -$79.58M2022: $1.19M2023: -$8.52M2024: -$6.11M2025: -$4.39M-$4.39M
2011Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$4.39M+28.2%
2024-$6.11M+28.3%
2023-$8.52M-815.6%
2022$1.19M+101.5%
2021-$79.58M+48.8%
2020-$155.54M-2.9%
2019-$151.21M-16.1%
2018-$130.22M-67.7%
2017-$77.63M+14.0%
2016-$90.25M-5.9%
2015-$85.19M-57.6%
2014-$54.04M-109.4%
2013-$25.81M-59.8%
2012-$16.15M-197.5%
2011-$5.43M—